# A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults

> **NCT07035769** · PHASE1 · RECRUITING · sponsor: **Debiopharm International SA** · enrollment: 88 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Debio 1453P
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07035769
- **Lead sponsor:** Debiopharm International SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-18
- **Primary completion:** 2026-10
- **Final completion:** 2026-11
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07035769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07035769, "A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07035769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*